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E-mail address: tmatsugu@dent.kagoshima-u.ac.jpLPS signaling is mediated through MyD88-dependent and -independent pathways, activating NF-jB,
MAP kinases and IRF3. Cot/Tpl2 is an essential upstream kinase in LPS-mediated activation of ERKs.
Here we explore the roles of MyD88 and Cot/Tpl2 in LPS-induced chemokine expression by studying
myd88/ and cot/tpl2/ macrophages. Among the nine LPS-responsive chemokines examined,
mRNA induction of ccl5, cxcl10, and cxcl13 is mediated through the MyD88-independent pathway.
Notably, Cot/Tpl2-ERK signaling axis exerts negative effects on the expression of these three chemo-
kines. In contrast, LPS-induced gene expression of ccl2, ccl7, cxcl2, cxcl3, ccl8, and cxcl9 is mediated in
the MyD88-dependent manner. The Cot/Tpl2-ERK axis promotes the expression of the ﬁrst four and
inhibits the expression of the latter two. Thus, LPS induces expression of multiple chemokines
through various signaling pathways in macrophages.
 2012 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
LPS from Gram-negative bacteria cell wall is sensed by Toll-like
receptor (TLR) 4 on the cell surface in collaboration with other
molecules, such as CD14, MD-2, and LPS-binding protein [1–3].
When bound to LPS, TLR4 activates two distinct intracellular signal
pathways in macrophages [4–7]. The myeloid differentiation factor
88 (MyD88)-dependent pathway is mediated by two adaptor mol-
ecules, MyD88 and TLR–IL-1 receptor domain containing adapter
protein (TIRAP), leading to the rapid activation of NF-jB and mito-
gen-activated protein kinases (MAPKs) inducing the production of
various pro-inﬂammatory cytokines [8–11]. The other ‘‘MyD88-on behalf of the Federation of Euro
yeloid differentiation factor
gen-activated protein kinase;
signal-regulated kinase; CCL,
motif ligand; TLR, Toll-like
ceptor-IL-1 receptor domain
ke; TRIF, Toll receptor-IL-1
g interferon-b; TPAM, TRIF-
kinase; TNF, tumor necrosis
ophages; JNK, c-Jun N-termi-
eaction; ISRE, IFN stimulus
(T. Matsuguchi).independent’’ pathway is mediated by two adaptor molecules, Toll
receptor–IL-1 receptor domain containing adaptor protein induc-
ing interferon-b (TRIF) and TRIF-related adaptor molecule (TRAM).
Recent reports have indicated that the activation of this MyD88-
independent pathway occurs after the endosomal translocation
of TLR4 from plasma membrane [12], thus inducing the production
of type I IFN through the activation of a transcription factor, IFN
regulatory factor (IRF) 3, as well as the late-phase activation of
NF-jB and MAPKs [13].
A serine/threonine protein kinase, Cot/Tpl2, is known as a mem-
ber of the MAP kinase kinase kinase family [14] and can activate
ERK and JNK signaling pathways as downstream targets [15]. We
and others have previously demonstrated that Cot/Tpl2 is indis-
pensable for the LPS-induced activation of ERKs in macrophages,
dendritic cells, and osteoblasts [16–19]. Lack of ERK activation in
cot/tpl2/ macrophages results in impaired secretion of tumor
necrosis factor (TNF) a and IL-23, along with the increased secre-
tion of IL-12, in response to LPS [18–21].
Secretion of various chemokines is induced from macrophages
by LPS as well as other TLR ligands [22,23]. Chemokines are gener-
ally considered as a group of cytokines which mainly have a role in
neutrophil and monocyte migration during acute and chronic
inﬂammation [24,25]. Essential roles of chemokines have been re-
ported in LPS-induced systemic shock and tissue injuries, indicatingpean Biochemical Societies.
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value in clinical conditions caused by endotoxemia [26,27]. How-
ever, the intracellular signals of LPS-mediated chemokine expres-
sion in macrophages have not been fully elucidated.
In our present study, intracellular signal transduction has been
explored for the LPS-induced production of nine chemokines by
examiningmyd88/ and cot/tpl2/mouseperitonealmacrophages
as well as the chemical inhibition of the ERK activation pathway.
2. Materials and methods
2.1. Animals
C57BL/6 mice (wild-type) were obtained from Japan Clea (To-
kyo, Japan). The cot/tpl2/ mice in the C57BL/6 background were
generated and maintained as described previously [28]. The
myd88/ mice in the C57BL/6 background were kindly provided
by Dr. Shizuo Akira (Osaka University, Japan). Animal experiments
were conducted in accordance with the institutional guidelines of
Kagoshima University for the care and use of experimental
animals.
2.2. Cell preparation and culture
Thioglycollate-elicited peritoneal macrophages (TEPMs) were
isolated from C57BL/6 and cot/tpl2/ mice as previously described
[16] with minor modiﬁcations. Brieﬂy, 8–15 week old age-matched
male mice were injected intraperitoneally with 2.5 ml of 5% thio-
glycollate broth (Sigma–Aldrich, St. Louis, MO). Three days later,
their peritoneal cavities were washed with 5 ml of cold PBS to col-
lect TEPMs. After 1 h incubation in aMEM containing 10% FCS and
subsequent washes with phosphate-buffered saline (PBS), the
remaining adherent cells were used in experiments. A mouse mac-
rophage cell line, RAW 264.7, was purchased from RIKEN cell bank
(Tsukuba, Japan).
2.3. Antibodies and reagents
Antibodies against JNKs, ERKs, p38 kinases, and IjBa, as well
as phosphor-speciﬁc antibodies against JNKs, ERKs, p38 kinases
and IRF3, were purchased from Cell Signaling Technology
(Danvers, MA). An antibody against glyceraldehydes-3-phosphate
dehydrogenase (GAPDH) was purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). LPS puriﬁed from Escherichia coli
O55:B5 by phenol-extraction and ion exchange chromatography
(catalog number L5418) was purchased from Sigma. Cyclohexi-
mide and U0126 were purchased from Calbiochem (San Diego,
CA).
2.4. Western blot analysis
For Western blot analyses, total cellular lysate preparation and
immunoblotting procedures were performed as previously de-
scribed [17].
2.5. Quantitative polymerase chain reaction (qPCR) analysis
Isolation of total RNA and qPCR were conducted as previously
described [17]. The primer sequences were described in Table 1.
2.6. Biological database search
The transcription factor binding sites in these gene promoters
were estimated with Transcription Element Search System (TESS)
programs (http://www.cbil.upenn.edu/cgi-bin/tess/tess).3. Results
3.1. LPS-induced chemokine gene expression is mediated through
either MyD88-dependent or independent signal pathway in mouse
TEPMs
Stimulation of TLR4 by LPS induces two distinct signal pathways
medicated by TIRAP/MyD88 (MyD88-dependent pathway) and
TRAM/TRIM (MyD88-independent pathway). Involvement of these
signal pathways in LPS-induced chemokine expression was ex-
plored using TEPMs fromwild-type andmyd88/mice. Out of che-
mokines examined, LPS signiﬁcantly induced the gene expression of
nine chemokines: Ccl2 (Mcp1), Ccl5 (Rantes), Ccl7 (Mcp3), Ccl8
(Mcp2), Cxcl2 (Mip2), Cxcl3 (Mip2b), Cxcl9 (Mig), Cxcl10 (Ip10),
and Cxcl13 (Blc) in wild-type TEPMs (Fig. 1). When myd88/ TEP-
Ms were stimulated by LPS, induction of ccl2, ccl7, ccl8, cxcl2, cxcl3,
and cxcl9 mRNA was markedly inhibited compared with those in
wild-type TEPMs (Fig. 1). In contrast to these six chemokines, the
mRNA of ccl5 and cxcl10 was induced by LPS in myd88/ TEPMs
to the similar levels to those in wild-type TEPMs, indicating that
MyD88 is not necessary for their response to LPS (Fig. 1). Expression
of cxcl13 mRNA was signiﬁcantly induced by LPS in myd88/ TEP-
Ms, although its induction level was lower than that in wild-type
TEPMs (Fig. 1).
3.2. Involvement of Cot/Tpl2 in the LPS-induced chemokine expression
Although Cot/Tpl2 is an essential kinase mediating TNF-a
expression in LPS-stimulated macrophages, its involvement in
LPS-induce chemokine expression has not been well documented.
TEPMs were isolated from cot/tpl2/ mice and their chemokine
mRNA induction by LPS was compared with wild-type and
myd88/ counterparts. Among the six chemokines whose expres-
sional response to LPS requires MyD88, ccl8 and cxcl9 mRNA was
induced by LPS in cot/tpl2/ TEPMs at higher levels than those
in wild-type TEPMs (Fig. 1). In contrast, LPS-induced mRNA levels
of ccl2, ccl7, cxcl2 and cxcl3 were signiﬁcantly lower in cot/tpl2/
TEPMs compared with wild-type macrophages (Fig. 1). Especially,
LPS-mediated induction of ccl7 mRNA was basically abolished
(Fig. 1). The inﬂuence of cot/tpl2 deﬁciency was similarly observed
in the presence of cycloheximide, a protein synthesis inhibitor,
indicating that Cot/Tpl2 is directly involved in the LPS signal trans-
duction inducing the expression of these six chemokines (Fig. 1).
As for the three chemokines, Ccl5, Cxcl10, and Cxcl13, which did
not require MyD88 for their mRNA induction by LPS, each mRNA
expression was induced in cot/tpl2/ TEPMs at higher levels to
those in wild-type TEPMs (Fig. 1). The increased expression of
these three chemokines in cot/tpl2/ TEPMs in comparison with
the wild-type TEPMs was similarly observed in the presence of
cycloheximide (Fig. 1). It is thus indicated that Cot/Tpl2 is not
essential for the MyD88-indepent mRNA induction of chemokines.
3.3. Inhibition of ERK activation exerts similar effects to Cot/Tpl2
deﬁciency on the chemokine expression proﬁle in LPS-stimulated
TEPMs
As it has previously been reported that Cot/Tpl2 is speciﬁcally
essential for the LPS-induced ERK activation signal in macrophages
[16–19], we next sought to examine the role of ERK activation in
LPS-induced chemokine expression in TEPMs. Being consistent
with previous reports [16], LPS-stimulated phosphorylation of
ERK was signiﬁcantly impaired, whereas phosphorylation of p38,
JNK and IRF3, as well as the degradation of IjBa, was normally in-
duced in cot/tpl2/ TEPMs in comparison with the wild-type con-
trol (Fig. 2A). Pretreatment with U0126, a speciﬁc inhibitor of
Table 1
Primers used in this study.
Gene
symbol
Primers [50–30] Gene bank Amplication
length
rpl13a GCTTACCTGGGGCGTCTG NM_009438 149bp (427–
575 nt)
ACATTCTTTTCTGCCTGTTTCC
tbp CAAACCCAGAATTGTTCTCCTT NM_013684 131bp (876–
1006 nt)
ATGTGGTCTTCCTGAATCCCT
ccl2 AGCACCAGCCAACTCTCACT NM_011333 136bp (38–173
nt)
CGTTAACTGCATCTGGCTGA
ccl5 ATATGGCTCGGACACCACTC NM_013653 131bp (113–
243 nt)
TTCTTCGAGTGACAAACACG
ccl7 CCTGGGAAGCTGTTATCTTCAA NM_013654 113bp (245–
357 nt)
TGGAGTTGGGGTTTTCATGTC
ccl8 GCTGTGGTTTTCCAGACCAA NM_021443 120bp (233–
352 nt)
GAAGGTTCAAGGCTGCAGAA
cxcl2 GAAGTCATAGCCACTCTCAAGG NM_009140 148bp (242–
389 nt)
TTCCGTTGAGGGACAGCA
cxcl3 CAGCCACACTCCAGCCTA NM_203320 113bp (46–158
nt)
CACAACAGCCCCTGTAGC
cxcl9 CGGACTTCACTCCAACACAG NM_008599 114bp (12–125
nt)
TAGGGTTCCTCGAACTCCAC
cxcl10 GGATCCCTCTCGCAAGGA NM_021274 136bp (102–
237 nt)
ATCGTGGCAATGATCTCAACA
cxcl13 CAGGCCACGGTATTCTGGA NM_018866 98bp (85–198
nt)
CAGGGGGCGTAACTTGAATC
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type TEPMs at 2.5 lM, while not affecting the other signals
(Fig. 2A).
Pretreatment of wild-type TEMPs with U0126 down-regulated
the LPS-induced mRNA induction of ccl2, ccl7, cxcl2, and cxcl3
(Fig. 2B). It should be noted that the mRNA induction of all these
four chemokines was impaired in cot/tpl2/ TEPMs (Fig. 1). In con-
trast, LPS-induced mRNA levels of ccl5, ccl8, cxcl9, cxcl10, and cxcl13
were moderately or signiﬁcantly higher with U0126 pretreatment
in wild-type TEPMs (Fig. 2B). Notably, the mRNA induction of these
six chemokines was not impaired in cot/tpl2/ TEPMs (Fig. 1).
Thus, the effects of U0126 treatment and cot/tpl2 deﬁciency on
the chemokine expression proﬁles were similar in LPS-stimulated
TEPMs.
Furthermore, U0126 pretreatment of myd88/ TEPMs signiﬁ-
cantly increased LPS-induced mRNA levels of three MyD88-inde-
pendent chemokines, Ccl5, Cxcl10, and Cxcl13 (Fig. 3). It is thus
indicated that ERK activation negatively regulates chemokine
induction in the MyD88-indepent LPS signal pathway.
3.4. The effects of MEK inhibitor on LPS-induced chemokine
expressions in RAW 264.7 cells
To further assess the inﬂuence of ERK signal pathway on LPS-in-
duced chemokine expression in macrophages, RAW 264.7 cells, a
mouse macrophage cell line, were stimulated with LPS after the
pretreatment with U0126 or vehicle. U0126 at 2.5 lM strongly
inhibited ERK phosphorylationwhereas did not affect the activationof p38, JNK, IRF3, or NF-jB pathway in LPS-treated RAW 264.7 cells
(Fig. 4A). Gene expression of the fore-mentioned nine chemokines
was also signiﬁcantly induced by LPS in RAW 264.7 cells (Fig. 4B).
Being similar to the expression pattern in TEPMs, U0126 pretreat-
ment down-regulated the LPS-induced mRNA induction of ccl2,
ccl7, cxcl2, and cxcl3, while it moderately or signiﬁcantly up-regu-
lated the LPS-induced mRNA levels of ccl5, ccl8, cxcl9, and cxcl10
in RAW264.7 cells (Fig. 4B). ThemRNA expression of cxcl13was be-
low the detection level in RAW 264.7 cells even after the LPS stim-
ulation (data not shown).
4. Discussion
In the present study, our data have revealed that the involve-
ment of MyD88, Cot/Tpl2, and ERK in LPS-induced chemokine
expression varies considerably depending on the kind of chemo-
kine. When LPS is sensed by TLR4, MyD88, along with TIRAP, func-
tions as an adaptor molecule inducing the activation of IRAKs,
which leads to the activation of downstream molecules, NF-jB
and MAPKs (MyD88-dependent pathway) [8–11]. TLR4 also re-
cruits two other adaptor molecules, TRAM and TRIF, inducing the
other signal pathway. This MyD88-independent pathway induces
phosphorylation/activation of IRF3 leading to the production of
IFN-b [12,13]. Among the nine LPS-responsive chemokines exam-
ined in our study, the LPS-induced expression is severely reduced
for ccl2, ccl7, ccl8, cxcl2, cxcl3, and cxcl9 in myd88/ TEPMs
(Fig. 1), indicating the induction of these six chemokines is regu-
lated by the MyD88-dependent pathway. In contrast, the induction
of ccl5, cxcl10, and cxcl13 by LPS remains intact inmyd88/ TEPMs,
indicating that the LPS-induced expression of these three chemo-
kines is regulated by MyD88-independent pathway in macro-
phages. A part of our result is consistent with a previous report
which showed that LPS-mediated expression of ccl5 and cxcl10 is
independent of MyD88 [29]. Mouse ccl5 gene promoter contains
IFN stimulus response element (ISRE) and NF-jB binding sites,
and both of these are essential for the mouse ccl5 promoter activity
[30]. The ISRE motif is also conserved in the human ccl5 gene pro-
moter, in which the essential role of IRF3 has been reported [31].
The combination of ISRE and NF-jB binding sites are also found
in the promoter region of mouse cxcl10 gene, and the functions
of both elements are essential for the transcriptional response to
LPS [32]. The functional importance of ISRE in both ccl5 and cxcl10
gene promoters is consistent with their responses to the MyD88-
independent pathway. The MyD88-independet pathway is also
capable to induce the activation of NF-jB pathway in a somewhat
slower time course than that by MyD88-dependent manner [13],
presumably enabling it to activate both ISRE and NF-jB binding
sites.
Our result has newly showed that CXCL13 can be induced by
LPS in a MyD88-independent manner in macrophages, being simi-
lar to CCL5 and CXCL10. CXCL13 interacts with CXCR5 and recruits
B cells as well as a subset of CD4+ T cells [33,34], and has previously
been reported to be induced by LPS in dendritic cells (DCs) [35].
The mouse cxcl13 gene promoter contains a functional NF-jB bind-
ing site at 115 of the transcriptional start site [36]. Although the
promoter structure of the mouse cxcl13 has not been fully eluci-
dated, a putative ISRE motif is located at 542, and may mediate
the responsiveness to the MyD88-independent pathway.
Notably, the LPS-induced mRNA expression of each of the three
‘‘MyD88-independent’’ chemokines was signiﬁcantly increased in
cot/tpl2/ TEPMs than in wild-type TEPMs (Fig. 1). Some of these
results are consistent with two recent studies which showed en-
hanced LPS-induced expression of ccl5 and cxcl10 mRNA in cot/
tpl2/ bone marrow-derived macrophages [20], and enhanced
CCL5-secretion from cot/tpl2-deﬁcient TEPMs [37]. Furthermore,
Fig. 1. Effects of cot/tpl2 and myd88 deﬁciencies on LPS-induced chemokine mRNA expression in macrophages. TEPMs from wild-type and cot/tpl2/ mice were left
unstimulated (black bar), or stimulated with 100 ng/ml LPS for 6 h in the absence (gray bars) or presence (white bar) of 1.0 lM cycloheximide. TEPMs from myd88/ mice
were left unstimulated (black bar), or stimulated with 100 ng/ml LPS for 6 h in the absence of cycloheximide (gray bars). Total RNA was analyzed by qPCR. Results of qPCR
are shown for ccl2, ccl5, ccl7, ccl8, cxcl2, cxcl3, cxcl9, cxcl10 and cxcl3. Fold increase represents an experimental value divided by the control (without LPS-treatment) value
for each chemokine. Vertical bars indicate mean SD of at least three different experiments. ⁄Signiﬁcant difference from the value of the wild-type group by ANOVA
(P < 0.01).
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MEK1/2 inhibitor in the wild-type and myd88/ TEPMs, as well
as in RAW 264.7 cells (except for CXCL13 which was not expressed
in RAW 264.7 cells) (Figs. 2B, 3 and 4). As Cot/Tpl2 is essential for
the LPS-induced ERK activation [18,28], it is suggested that Cot/
Tpl2-mediated ERK activation is not necessary but rather inhibi-
tory for the MyD88-independent induction of chemokine expres-
sion in macrophages. This proposal is consistent with the
unimpaired IRF3 phosphorylation by LPS in Cot/Tpl2-deﬁcient cells
and cells treated with ERK inhibitor (Figs. 2A and 4A).
The mRNA induction of six chemokines (CCL2, CCL7, CCL8,
CXCL2, CXCL3, and CXCL9) by LPS is severely impaired in
myd88/ TEPMs compared with the wild-type control, indicating
that MyD88-dependent signal is essential for their transcription.
Among these chemokines, the involvement of Cot/Tpl2 in their
mRNA response to LPS seems quite different. The mRNA levels of
ccl2, ccl7, cxcl2 and cxcl3 after LPS stimulation were signiﬁcantly
lower, while those of ccl8 and cxcl9 were signiﬁcantly higher in
cot/tpl2/ TEPMs than in wild-type controls. A part of this result
is consistent with a previous report which demonstrated that
LPS-induced CCL2 secretion was decreased in cot/tpl2/ TEPMs
compared with that of wild-type counterparts [37]. Intriguingly,
a speciﬁc MEK1/2 inhibitor exerted similar effects to cot/tpl2 deﬁ-
ciency, up-regulating ccl8 and cxcl9 mRNA, while down-regulating
ccl2, ccl7, cxcl2 and cxcl3mRNA, in both wild-type TEPMs and RAW
264.7 cells (Figs. 2 and 4). Thus it is indicated that the functional
involvement of Cot/Tpl2 in MyD88-dependent chemokine induc-
tion by LPS is at least mainly through the activation of ERK.Previous investigations have shown that two transcription fac-
tors, NF-jB and PU.1, play critical roles in the gene promoter func-
tions of ccl2, ccl7, and cxcl2 in mouse macrophages [38–41].
Additionally, mouse cxcl3 promoter has a putative PU.1 site at
1030 from the transcriptional start site. Previous reports have
demonstrated that ERK activation is essential for the phosphoryla-
tion and DNA-binding activities of PU.1 in cytokine-stimulated
mouse granulocytes [42] and in hematopoietic stem cells [43],
although ERK may not directly phosphorylate PU.1 [43]. Thus, it
is reasonable to speculate that Cot/Tpl2-ERK activation by LPS
mediates ccl2, ccl7, cxcl2, and cxcl3 mRNA expression through
the activation of PU.1.
In contrast to the above four chemokines, the transcriptional
induction of ccl8 and cxcl9 by LPS was promoted by the deﬁciency
of Cot/Tpl2 promoted, being similar to that of three ‘‘MyD88-inde-
pendent’’ chemokines, ccl5, cxcl10, and cxcl13. The molecular
mechanisms how Cot/Tpl2-ERK pathway exerts inhibitory effects
on the LPS-induced transcription of these chemokines are currently
unknown. One possible candidate is early growth response-1 (Egr-
1) which is a DNA-binding protein induced by MEK1/2-ERK signal
in various cell types [44]. It has recently been reported that Egr-1
functions as a transcriptional repressor to mediate the down-regu-
lation of smooth muscle a-actin gene expression by TNF-a [44].
Intriguingly, deregulated expression of CXCL9 has been reported
in Egr-1 knockout mice [45], indicating that Egr-1 may function
as a transcriptional repressor on the mouse cxcl9 gene. In addition,
the mouse cxcl9 and ccl5 gene, which have been up-regulated by
cot/tpl2 deﬁciency, have similar sequences to Egr-1 binding site
Fig. 2. (A) Activation of MAPK, IRF3, and NF-jB signal pathways in LPS-stimulated macrophages. TEPMs (isolated from wild-type and cot/tpl2/ mice) were pretreated with
2.5 lM U0126 or DMSO for 30 min and then left unstimulated or stimulated with 100 ng/ml LPS for 15 or 120 min. Western blot analysis was performed with speciﬁc
antibodies against phospho-ERK1/2, ERK1/2, phospho-JNK1/2, JNK1/2, phospho-p38 MAPK, p38, phospho-IRF3, IjB and GAPDH. (B) Effects of MEK1/2-ERK signal axis on
chemokine gene expression in TEPMs. TEPMs from wild-type mice were pretreated with 2.5 lM U0126 or DMSO for 30 min and then left unstimulated or stimulated with
100 ng/ml LPS for 6 h. Total RNA was analyzed by qPCR. Results of qPCR are shown for ccl2, ccl5, ccl7, ccl8, cxcl2, cxcl3, cxcl9, cxcl10 and cxcl13. Fold increase represents an
experimental value divided by the control (without LPS-treatment) value for each chemokine. Vertical bars indicate mean SD of at least three different experiments.
⁄Signiﬁcant difference from the value of the LPS-treated group by ANOVA (P < 0.01).
Fig. 3. Effects of MEK1/2-ERK signal axis on the myd88-independent chemokine mRNA induction by LPS. TEPMs from wild-type and myd88/ mice were left unstimulated
(black bar), or stimulated with 100 ng/ml LPS for 6 h in the absence (white bars) or presence (gray bar) of 2.5 lM U0126. Total RNA was analyzed by qPCR for ccl5, cxcl10 and
cxcl13. Fold increase represents an experimental value divided by the control (without LPS-treatment) value for each part. Vertical bars indicate mean SD of at least three
different experiments. ⁄Signiﬁcant difference from the value of the LPS-treated group by ANOVA (P < 0.01).
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Fig. 4. (A) Activation of MAPK, IRF3, and NF-jB signal pathways in LPS-stimulated RAW 264.7 cells. RAW 264.7 cells were pretreated with 2.5 lM U0126 or DMSO for
30 min and then left unstimulated or stimulated with 100 ng/ml LPS for 15 or 120 min. Western blot analysis was performed with speciﬁc Ab against phospho-ERK1/2,
ERK1/2, phospho-JNK1/2, JNK1/2, phospho-p38 MAPK, p38, phospho-IRF3, IjB or GAPDH. (B) Effects of MEK-ERK on chemokine gene expression in RAW 264.7 cells. RAW
264.7 cells were pretreated with 2.5 lM U0126 or DMSO for 30 min and then left unstimulated or stimulated with 100 ng/ml LPS for 6 h. Total RNA was analyzed by qPCR.
Results of qPCR are shown for ccl2, ccl5, ccl7, ccl8, cxcl2, cxcl3, cxcl9 and cxcl10. Fold increase represents an experimental value divided by the control (without LPS-
treatment) value for each part. Vertical bars indicate mean SD of at least three different experiments. ⁄Signiﬁcant difference from the value of the LPS-treated group by
ANOVA (P < 0.01).
K. Bandow et al. / FEBS Letters 586 (2012) 1540–1546 1545on those promoters. The possible regulatory role of Egr-1 in the
transcription of other chemokine genes, however, has not been
elucidated and needs further studies.
In summary, this study has shown that the role of MyD88 and
Cot/Tpl2 in LPS-induced chemokine expression in macrophages
considerably varies depending on the kind of chemokine. Cot/
Tpl2 in macrophages has been reported to regulate LPS-induced
cytokine expression in positive (TNF-a and IL-23) or negative (IL-
12) manner [18–21]. This present study further indicated that
Cot/Tpl2 directly regulates transcription of various chemokines in
LPS-stimulated macrophages. Thus, Cot/Tpl2 may be an intriguing
target to develop therapeutic drugs against inﬂammatory patholo-
gies induced by Gram-negative bacteria.Acknowledgments
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